Laparoscopic sleeve gastrectomy in obese patients with ventricular assist devices: a data note

BMC Research Notes

Bader Aldeen Alhafez¹  Juan Francisco Loro-Ferrer²  Kiran Garikapati³  Stacy A. Mandras⁴  Carl J. Lavie⁴  Hector O. Ventura⁴  Clement Eiswirth⁴  Selim Krim⁴  Sapna Desai⁴  Hamang Patel⁴  Adrian daSilva-deAbreu⁵ 

[1] Department of Internal Medicine, The Ohio State University, Columbus, OH, USA;Doctoral School, Universidad de Las Palmas de Gran Canaria, Las Palmas, Spain;The John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA, USA;The John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA, USA;Ochsner Clinical School, Faculty of Medicine, The University of Queensland, New Orleans, LA, USA;The John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA, USA;Ochsner Clinical School, Faculty of Medicine, The University of Queensland, New Orleans, LA, USA;Doctoral School, Universidad de Las Palmas de Gran Canaria, Las Palmas, Spain;

关键词: Heart failure;    Ventricular assist devices;    Heart-assist devices;    Bariatric surgery;    Laparoscopic sleeve gastrectomy;    Weight loss;    Body mass index;    Heart transplantation;    Metabolism;    Echocardiography;   

DOI  :  10.1186/s13104-020-05272-2

来源: Springer

【 摘 要 】

ObjectivesPatients with end-stage heart failure (ESHF) treated with ventricular assist devices (VADs) tend to gain weight after implantation, which is associated with higher complication rates and is a contraindication for heart transplantation (HT). The objective was to analyze the outcomes of obese patients with ESHF and VADs who underwent laparoscopic sleeve gastrectomy (LSG) at Ochsner Medical Center in New Orleans, which is the only program performing VADs and HT in the State of Louisiana, and also one of the largest VAD centers in the USA.Data descriptionThis dataset contains detailed baseline, perioperative, and long-term data of patients with VADs undergoing LSG. These variables were collected retrospectively from electronic medical records. Patients who achieved ≥ 50% excess BMI loss, BMI ≤ 35 kg/m2, listing for HT, HT, or myocardial recovery were identified and the timing to each of these milestones was documented. These data can be used alone or in combination with other datasets to achieve a larger sample size with more power for further analysis of these variables, which include the most important, standard, and objective bariatric and ESHF outcomes of patients with VADs undergoing LSG. Elaboration of composite outcomes is feasible.

【 授权许可】

CC BY